Admin
26th October 2009, 09:52 PM
Allopurinol Combination Study (RDEA594-203)
To compare the proportion of subjects whose serum urate (sUA) levels are < 6.0 mg/dL following 4 weeks of continuous treatment of RDEA594 in combination with allopurinol to allopurinol alone in subjects with documented inadequate hypouricemic response with standard doses of allopurinol.
Link to study (http://clinicaltrials.gov/ct2/show/NCT01001338)
To compare the proportion of subjects whose serum urate (sUA) levels are < 6.0 mg/dL following 4 weeks of continuous treatment of RDEA594 in combination with allopurinol to allopurinol alone in subjects with documented inadequate hypouricemic response with standard doses of allopurinol.
Link to study (http://clinicaltrials.gov/ct2/show/NCT01001338)